Next 10 |
AERWINS Technologies Inc. (AWIN) is expected to report for Q1 2024 Minera IRL Ltd ADR (MRLLY) is expected to report for quarter end 2023-09-30 SmileDirectClub, Inc. - Ordinary Shares - Class A (SDCCQ) is expected to report $-0.1 for Q3 2023 NextPlay Technologies Inc. (NXTP) is expecte...
Manhattan Scientifics, Inc. (MHTX) is expected to report for Q1 2024
Manhattan Scientifics Inc. ( OTC: MHTX ), announces that Siemens & Imagion Biosystems (IBX:ASX) collaborate. U.S. Founder MHTX owns 50 million Shares of Imagion Biosystems. For further details, please see Imagion Biosystems Press Release About Manhattan Scientifics, Inc....
Manhattan Scientifics Inc. ( OTCQB: MHTX ), which provided the initial funding &, currently owns more than 50 million shares of Imagion Biosystems Ltd. celebrates Imagion's remarkable progress in early cancer detection technology. In 2022, Imagion unveiled groundbreaking imaging agent...
Manhattan Scientifics Inc. ( OTCQB: MHTX ), announces positive early results from Imagion Biosystems Cancer Diagnostic human study. Imagion Biosystems Ltd. ( IBX.AX ) shares were up 46% trading 71 million shares. Manhattan Scientifics Inc., initially funded and is the cu...
Manhattan Scientifics Inc. ( OTC: QB ), initially funded and is the current owner of more that 50 million shares of Imagion Biosystems Ltd. ( IBX.AX ). Here we provide the reader with a televised interview with Imagion's CEO Bob Proulx. Stock Down Under Interview with Bob ...
Manhattan Scientifics Inc. ( OTCQB: MHTX ) invested $30 million and a 10-year effort to commercialize the Imagion Biosystems ( IBX: AX ) super early, non- invasive, non-radioactive Cancer diagnostic, now “partnered” with MD Anderson Cancer Center, Houston. The comp...
Manhattan Scientifics Inc. ( OTCQB: MHTX ) a company that acquires, develops and commercializes life-enhancing technologies is pleased to announce year-end business updates on its two nano technologies for 2020: its Nano-Medicine Cancer and Nano-Medical Metal Alloy ventures. N...
A Medical Imaging Breakthrough. MagSense™ Technology Will Help Transform Cancer Care Manhattan Scientifics Inc. (MHTX: OTCQB) provides a 45-minute interview with Imagion Biosystems Chairman/CEO Bob Proulx describing the very-early-cancer-diagnostic development that MH...
Manhattan Scientifics, Inc. ( OTCQB:MHTX ) owns 50+ Million shares of its former wholly-owned subsidiary cancer diagnostic company Imagion Biosystems Ltd. ( AX:IBX ). Volume trading yesterday exceeded 80 million shares @ high of AU $0.010. Manhattan Scientifics acquired and funded 10 years ea...
News, Short Squeeze, Breakout and More Instantly...
Manhattan Scientifics Inc Company Name:
MHTX Stock Symbol:
OTCMKTS Market:
Manhattan Scientifics Inc Website:
AERWINS Technologies Inc. (AWIN) is expected to report for Q1 2024 Minera IRL Ltd ADR (MRLLY) is expected to report for quarter end 2023-09-30 SmileDirectClub, Inc. - Ordinary Shares - Class A (SDCCQ) is expected to report $-0.1 for Q3 2023 NextPlay Technologies Inc. (NXTP) is expecte...
Manhattan Scientifics, Inc. (MHTX) is expected to report for Q1 2024
Manhattan Scientifics Inc. ( OTC: MHTX ), announces that Siemens & Imagion Biosystems (IBX:ASX) collaborate. U.S. Founder MHTX owns 50 million Shares of Imagion Biosystems. For further details, please see Imagion Biosystems Press Release About Manhattan Scientifics, Inc....